pS2 expression in infiltrating ductal carcinoma of the breast correlates with oestrogen receptor positivity but not with histological grade and lymph node status

Pathology

Volumn 33, Issue 3, 2001, Pages 283-286

  Looi, L M ^a   Wy Wan Azura, ^a   Cheah, P L ^a   Ng, M H ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Breast cancer prognosis; Estrogen receptor; Oestrogen receptor; pS2

Indexed keywords

ESTROGEN RECEPTOR; MONOCLONAL ANTIBODY; PROTEIN PS2;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER GRADING; CANCER INFILTRATION; CANCER INVASION; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALAYSIA; PROTEIN EXPRESSION;

EID: 0034907730     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/00313020126321     Document Type: Article

References (30)

1. The value of estrogen and progesterone receptors in the treatment of breast cancers
2. Receptors and response to endocrine therapy
3. Classification of breast cancer cells on the basis of a functional assay for estrogen receptor
4. Intestinal trefoil factor (TFF 3) and pS2 (TFF 1), but not spasmolytic polypeptide (TFF 2) mRNAs are co-expressed in normal, hyperplastic, and neoplastic human breast epithelium
5. Cloning of estrogen-regulated messenger RNA sequences from human breast cancer cells
6. Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence
7. Prognostic significance of the estrogen-regulated proteins, cathepsin-D and pS2, in breast cancer
8. Expression of the oestrogen responsive protein pS2 in human breast cancer
9. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up
10. Correlation between oestrogen receptor protein expression in infiltrating ductal carcinoma of breast by immunohistochemistry and cytosol measurements
11. Effect of tamoxifen on pS2 expression in human breast cancers
12. Expression of pS2 protein and estrogen and progesterone receptor status in breast cancer
13. Immunohistochemical detection of pS2 protein in paraffin sections of breast carcinoma tissue. Comparison with results of an immunoradiometry assay
14. Expression of pS2 estrogen-inducible protein in primary breast cancer
15. Immunoradiometric measurement of pS2 in breast cancer - Correlation with steroid receptors and plasminogen activators
16. Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7
17. Hormonal regulation of synthesis and secretion of pS2 protein relevant to growth of human breast cancer cells (MCF-7)
18. pS2 and response to adjuvant hormone therapy in primary breast cancer
19. Relationship of pS2 with response to tamoxifen therapy in patients with recurrent breast cancer
20. PS2 mRNA expression adds prognostic information to node status for 6-year survival in breast cancer
21. pS2 expression and response to hormonal therapy in patients with advanced breast cancer
22. pS2 protein: A marker improving prediction of response to neoadjuvant tamoxifen in postmenopausal breast cancer patients
23. The 5′ flanking region of the pS2 gene contains a complex enhancer region responsive to estrogens, epidermal growth factor, a tumour promoter (TPA), the c-Ha-ras oncoprotein and the c-jun protein
24. Trefoil proteins: Their role in normal and malignant cells
25. Effect of basic fibroblast growth factor on synthesis/secretion of pS2 protein by human breast cancer cells (MCF-7)
26. Modulation of cathepsin-D and pS2 protein levels in human breast cancer cell lines
27. Sequence of the pS2 mRNA induced by estrogen in the human breast cancer line MCF-7
28. Complete primary structure of human estrogen responsive gene (pS2) product
29. Chromatin structure of the regulatory regions of pS2 and cathepsin D genes in hormone-dependent and -independent breast cancer cell lines
30. Messenger RNA determination of estrogen receptor, progesterone receptor, pS2, and plasminogen activator inhibitor-1 by competitive reverse transcription-polymerase chain reaction in human breast cancer